Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.3852
-0.0047 (-1.21%)
Apr 25, 2025, 12:41 PM EDT - Market open
Harvard Bioscience Employees
As of December 31, 2024, Harvard Bioscience had 355 total employees, including 330 full-time and 25 part-time employees. The number of employees decreased by 61 or -14.66% compared to the previous year.
Employees
355
Change (1Y)
-61
Growth (1Y)
-14.66%
Revenue / Employee
$265,169
Profits / Employee
-$34,944
Market Cap
16.98M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
HBIO News
- 14 days ago - Harvard Bioscience Announces CFO Transition - GlobeNewsWire
- 6 weeks ago - Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025 - GlobeNewsWire
- 6 weeks ago - Harvard Bioscience, Inc. (HBIO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting - GlobeNewsWire
- 2 months ago - Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET - GlobeNewsWire
- 3 months ago - Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference - GlobeNewsWire
- 5 months ago - Harvard Bioscience, Inc. (HBIO) Q3 2024 Earnings Call Transcript - Seeking Alpha